Delcath Systems ($DCTH): Expanding Beyond Metastatic Uveal Melanoma with HEPZATO...
Delcath Systems' HEPZATO KIT, an FDA-approved liver-directed therapy, is a breakthrough yet initially serves a limited market. The true investment potential rests in expanding its innovative technology to treat larger...